WP
GSK icon

WealthSource Partners’s GSK GSK Stock Holding History

WealthSource Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,334
Closed -$236K – 516
2022
Q2 		$236K Sell
4,334
-2,368
-35% -$131K 0.02% 451
2022
Q1 		$365K Sell
6,702
-1,156
-15% -$62.8K 0.02% 407
2021
Q4 		$433K Sell
7,858
-288
-4% -$15K 0.03% 338
2021
Q3 		$389K Buy
8,146
+1,082
+15% +$54.3K 0.03% 333
2021
Q2 		$352K Buy
7,064
+2,332
+49% +$112K 0.03% 333
2021
Q1 		$211K Buy
4,732
+244
+5% +$11.1K 0.02% 403
2020
Q4 		$206K Hold
4,488
– – 0.02% 357
2020
Q3 		$211K Hold
4,488
– – 0.03% 326
2020
Q2 		$229K Sell
4,488
-317
-7% -$16.3K 0.03% 288
2020
Q1 		$228K Sell
4,805
-395
-8% -$21.1K 0.04% 280
2019
Q4 		$305K Buy
5,200
+470
+10% +$26.1K 0.04% 308
2019
Q3 		$252K Sell
4,730
-10
-0.2% -$514 0.04% 352
2019
Q2 		$237K Buy
4,740
+114
+2% +$5.72K 0.04% 387
2019
Q1 		$242K Sell
4,626
-340
-7% -$17K 0.05% 298
2018
Q4 		$237K Sell
4,966
-137
-3% -$6.75K 0.07% 245
2018
Q3 		$256K Sell
5,103
-91
-2% -$4.62K 0.07% 244
2018
Q2 		$262K Buy
5,194
+157
+3% +$7.91K 0.07% 229
2018
Q1 		$246K Buy
5,037
+408
+9% +$19K 0.07% 239
2017
Q4 		$205K Buy
4,629
+473
+11% +$21.9K 0.06% 281
2017
Q3 		$211K Sell
4,156
-8
-0.2% -$406 0.07% 266
2017
Q2 		$224K Hold
4,164
– – 0.08% 249
2017
Q1 		$219K Buy
+4,164
New +$211K 0.08% 248
2016
Q4 		– Sell
-4,155
Closed -$224K – 259
2016
Q3 		$224K Sell
4,155
-1,379
-25% -$75.6K 0.08% 223
2016
Q2 		$300K Buy
+5,534
New +$292K 0.11% 169

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

WealthSource Partners's GSK Position: Q3 2022 in Review

WealthSource Partners sold out of GSK (GSK) in Q3 2022, closing a stake of 4,334 shares — an estimated $236K sold.

WealthSource Partners first reported a position in GSK in Q2 2016 and held it in 24 quarters. The position peaked at $433K in Q4 2021. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • WealthSource Partners reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • WealthSource Partners sold 4,334 GSK shares in Q3 2022, an estimated $236K.
  • WealthSource Partners first reported a position in GSK in Q2 2016 and held it in 24 quarters.
  • WealthSource Partners's GSK position peaked at $433K in Q4 2021.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on WealthSource Partners's 13F filing for Q3 2022, filed 15 Nov 2022.